1-181483801-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001205293.3(CACNA1E):c.57G>A(p.Ser19Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000311 in 1,613,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00018 ( 0 hom. )
Consequence
CACNA1E
NM_001205293.3 synonymous
NM_001205293.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0780
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.43).
BP6
Variant 1-181483801-G-A is Benign according to our data. Variant chr1-181483801-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 767734.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.078 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00159 (242/151944) while in subpopulation AFR AF= 0.0055 (228/41458). AF 95% confidence interval is 0.00491. There are 0 homozygotes in gnomad4. There are 105 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 242 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1E | NM_001205293.3 | c.57G>A | p.Ser19Ser | synonymous_variant | 1/48 | ENST00000367573.7 | NP_001192222.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1E | ENST00000367573.7 | c.57G>A | p.Ser19Ser | synonymous_variant | 1/48 | 1 | NM_001205293.3 | ENSP00000356545.2 | ||
CACNA1E | ENST00000360108.7 | c.57G>A | p.Ser19Ser | synonymous_variant | 1/47 | 5 | ENSP00000353222.3 | |||
CACNA1E | ENST00000367570.6 | c.57G>A | p.Ser19Ser | synonymous_variant | 1/47 | 1 | ENSP00000356542.1 | |||
CACNA1E | ENST00000621791.4 | c.57G>A | p.Ser19Ser | synonymous_variant | 1/46 | 1 | ENSP00000481619.1 | |||
CACNA1E | ENST00000524607.6 | c.492G>A | p.Ser164Ser | synonymous_variant | 3/12 | 5 | ENSP00000432038.2 |
Frequencies
GnomAD3 genomes AF: 0.00160 AC: 243AN: 151826Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
243
AN:
151826
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000483 AC: 120AN: 248594Hom.: 0 AF XY: 0.000311 AC XY: 42AN XY: 134954
GnomAD3 exomes
AF:
AC:
120
AN:
248594
Hom.:
AF XY:
AC XY:
42
AN XY:
134954
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000177 AC: 259AN: 1461168Hom.: 0 Cov.: 31 AF XY: 0.000155 AC XY: 113AN XY: 726852
GnomAD4 exome
AF:
AC:
259
AN:
1461168
Hom.:
Cov.:
31
AF XY:
AC XY:
113
AN XY:
726852
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00159 AC: 242AN: 151944Hom.: 0 Cov.: 31 AF XY: 0.00141 AC XY: 105AN XY: 74258
GnomAD4 genome
AF:
AC:
242
AN:
151944
Hom.:
Cov.:
31
AF XY:
AC XY:
105
AN XY:
74258
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 27, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 26, 2021 | - - |
Developmental and epileptic encephalopathy, 69 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 17, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at